Aldeyra Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Lexington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Aldeyra Therapeutics, Inc. has filed 645 SEC EDGAR filings since 06 Oct 2005

SEC filing history

Showing 201-225 of 643 matching filings.

Per page
25
Current page
9
3

FORM 3 SUBMISSION

Filing date
13 May 2022
Reporting date
10 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date
05 May 2022
Reporting date
05 May 2022
Next action
Verify source filing
8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date
28 Apr 2022
Reporting date
25 Apr 2022
Next action
Verify source filing
DEFA14A File 001-36332

DEFA14A

Filing date
25 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36332

DEF 14A

Filing date
25 Apr 2022
Reporting date
07 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Apr 2022
Reporting date
30 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Apr 2022
Reporting date
30 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Apr 2022
Reporting date
30 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-263660

S-8

Filing date
17 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date
17 Mar 2022
Reporting date
17 Mar 2022
Next action
Verify source filing
SC 13G/A File 005-88182

SC 13G/A

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88182

SC 13G filing

Filing date
09 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88182

SC 13G filing

Filing date
04 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88182

SCHEDULE 13G/A

Filing date
04 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date
09 Nov 2021
Reporting date
09 Nov 2021
Next action
Verify source filing
8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date
28 Oct 2021
Reporting date
28 Oct 2021
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Jun 2021
Reporting date
08 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .